Biofrontera (BFRI) Return on Capital Employed (2021 - 2025)

Biofrontera's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 112.39% for Q4 2025.

• On a quarterly basis, Return on Capital Employed rose 9527.0% year-over-year to 112.39% in Q4 2025; TTM through Dec 2025 was 112.39%, a 9527.0% increase from a year earlier, with the FY2025 full-year figure at 84.45%, up 4798.0% from the prior year.
• Return on Capital Employed grew to 112.39% in Q4 2025 per BFRI's latest filing, from 337.12% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 1232.83% in Q2 2025 and bottomed at 337.12% in Q3 2025.
• The 5-year median for Return on Capital Employed is 137.78% (2024), against an average of 25.22%.
• Across the five-year window, Return on Capital Employed sank 46711 bps in 2022 and surged 137061 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 409.31% in 2021, then slumped by 114 bps to 57.8% in 2022, then tumbled by 203 bps to 175.38% in 2023, then fell by 18 bps to 207.66% in 2024, then surged by 46 bps to 112.39% in 2025.
• Per Business Quant, the three latest BFRI Return on Capital Employed figures stand at 112.39% (Q4 2025), 337.12% (Q3 2025), and 1232.83% (Q2 2025).